Clinically Proven Effectiveness of Revaginal Ovules for Intimate Health and Vaginal Tissue Regeneration
Gruppo FarmaImpresa is pleased to present the results of its clinical study on Revaginal Ovules, a CE-certified medical device developed to promote vaginal and uterine tissue regeneration in a hormone-free formulation.
The product proved to be highly effective and well tolerated among women of reproductive age, perimenopause, and menopause, and is compatible with condom use. These results underline the therapeutic value and safety of Revaginal Ovules for women’s intimate health.
Vaginal Health and Tissue Regeneration
The vaginal ecosystem is sensitive and affected by hormonal changes, antibiotic or contraceptive use, sexual activity, and stress. Vaginitis and bacterial vaginosis (BV) are among the most common complaints.
Revaginal Ovules supports vaginal balance and regeneration through a formula that includes:
- Hyaluronic Acid
- Lactic Acid
- Policarbophil
- Glycyrrhetinic Acid
- Vitamins A and E
- Tea Tree Oil
These actives contribute to mucosal healing, microbiota protection, and long-term balance.
Clinical Study: Methodology and Results
20 women (aged 29–74) with symptoms such as burning, dryness, and pain were evaluated using the VSQ (Vulvovaginal Symptoms Questionnaire) at baseline (T0) and after treatment (T1).
Results:
- Average VSQ score reduced by 8.8 points (89% improvement)
- 75% of patients reported complete resolution of symptoms
- Emotional distress decreased from 70% to 13%
- Sexual impact dropped from 80% to 13%
- Dyspareunia reduced from 60% to 19%
Main symptom reduction:
- Vaginal dryness: from 60% to 6%
- Irritation: from 65% to 6%
- Burning: from 60% to 0%
Conclusions
Revaginal Ovules is a clinically effective and natural solution for vaginal regeneration, dryness, and irritation. No adverse effects were reported.
Looking for a B2B-ready or private label solution?
We are certified manufacturers of medical devices, dietary supplements, and cosmetics. Revaginal Ovules is ready for market entry or private labeling, with full regulatory and clinical support.
